Evaluation of Safety and Efficacy of Intranasal Administration of iPS Cell-derived Exosomes in Mild Cognitive Impairment

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2025
This article has no abstract
Epistemonikos ID: 8644c86b1c295319798f3ec3b55c522d0f00c948
First added on: Apr 24, 2026